AM3506 was administered at a dose of 0 or 1.0 mg/kg 60 min before extinction training. SR141716 (0 or 2 μg/μl) was bilaterally infused into the BLA 5 min before systemic treatment with 1.0 mg/kg AM3506. A control group of mice treated with vehicle instead of each drug was also included and tested in the same manner. The purpose of this experiment was to test whether the extinction-facilitating effect of AM3506 was dependent on the action at CB1R in the BLA. The effect of drug treatment on freezing during retrieval was statistically analyzed using ANOVA, followed by Newman–Keuls post hoc tests.